Medication info
Telmicom Tablet 80/5 mg

Telmicom Tablet 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Independ Bio Pharmaceutical Co., Ltd.
Appearance
White and light blue, double-convex, oval-shaped tablet
Packaging
30 tablets/box [(10 tablets/PTP*3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201906080 · Approved 2019.08.27 · Insurance code 057700330

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine); however, if blood pressure is not controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution when receiving this medication.’) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a lower dose and increase the dose gradually.
Child dose
The safety and efficacy of this medication have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Independ Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication can effectively lower blood pressure in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using telmisartan or amlodipine. Such treatment helps to maintain stable blood pressure, reduce cardiovascular risk, and support overall health. In other words, this medication is used to improve blood pressure control in essential hypertension.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine); however, if blood pressure is not controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution when receiving this medication.’) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a lower dose and increase the dose gradually.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication should not be taken by pregnant women, especially during the second and third trimesters, as it can cause serious harm to the fetus. This medication should not be administered to patients with certain conditions, such as those allergic to this drug or its active ingredients, pregnant women, nursing mothers, patients with severe liver dysfunction, or those with severe heart diseases. Additionally, patients with primary aldosteronism, valvular heart disease, liver dysfunction, gastrointestinal diseases, renal artery stenosis, renal failure, elderly patients, etc., should use this medication with extreme caution. Common side effects may include dizziness, peripheral edema, and hypotension, while serious side effects have been reported rarely. Therefore, any unusual symptoms should be discussed with healthcare providers immediately. During pregnancy, the use of this medication may be risky for the fetus, so if pregnancy is confirmed, it should be discontinued immediately and switched to a safer alternative. As this medication lowers blood pressure, patients at risk of hypotension should consult a physician before taking it and monitor blood pressure and symptoms carefully during treatment. As potassium levels may increase in the blood, patients with reduced kidney function or heart failure should regularly check potassium levels through blood tests. This medication can affect kidney function, so patients with kidney disorders should have their kidney function monitored through blood tests while taking it. Particularly, patients with myocardial infarction or angina may experience worsening symptoms with this medication, so caution is required. This medication may cause drowsiness or dizziness while driving or operating machinery; therefore, caution is necessary during treatment. There may be interactions with other drugs, so if you are currently taking other medications, you must inform your doctor or pharmacist. This medication is not recommended for nursing women; therefore, nursing should be avoided. It is not recommended for pediatric patients due to insufficient proof of safety and efficacy. Elderly patients may be more sensitive to this medication, so dosage adjustments and caution are necessary during treatment. In cases of overdose, hypotension, tachycardia, dizziness, and in severe cases, shock may occur, requiring immediate treatment from medical facilities. This medication should be stored out of reach of children and is sensitive to moisture; therefore, it should be opened and administered just before use.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory decrease
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle hypertonicity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormality
  • liver dysfunction
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urination disorders
  • pollakiuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container to protect it from light and air, maintaining a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

White and light blue, double-convex, oval-shaped tablet

Package unit

30 tablets/box [(10 tablets/PTP*3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.